ICD-10 Code D66: Hereditary factor VIII deficiency (Hemophilia A)

Key Takeaways

ICD-10 Code D66 is a billable ICD-10-CM code for hereditary factor VIII deficiency, effective October 1, 2025 (FY2026)

D66 covers Hemophilia A, classical hemophilia, Hemophilia NOS, and deficiency factor VIII with functional defect

Excludes1 restriction: never code D66 alongside D68.0 (factor VIII deficiency with vascular defect / von Willebrand disease)

Pabau’s claims management software supports accurate ICD-10 code entry and reduces claim denials tied to coding errors

ICD-10 Code D66 is a billable ICD-10-CM code for hereditary factor VIII deficiency, more commonly known as Hemophilia A. It covers classical hemophilia, Hemophilia NOS, and deficiency factor VIII with a functional defect. Its one Excludes1 restriction, against D68.0, is what trips up most claims.

This reference covers the 2026 billable status, applicable-to inclusions, Excludes1 and Excludes2 notes, the D65-D69 hierarchy, related codes, CPT pairings, the ICD-9 crosswalk, and documentation guidance.

ICD-10 Code D66: Definition, billable status, and 2026 edition details

ICD-10 Code D66 is a billable and specific ICD-10-CM code for hereditary factor VIII deficiency. It is valid for reimbursement purposes and can be used as a principal or secondary diagnosis on a claim. The 2026 edition of D66 became effective on October 1, 2025, under the CMS ICD-10-CM update cycle.

Primary care and general practice software need to recognize D66 accurately too, since these visits often trigger the initial hematology referral.

Because D66 is a terminal (leaf-level) code, no further specificity is required. Coders do not need to select a sub-code beneath D66.

That said, the absence of a sub-code structure does not mean documentation requirements are lighter. Payers routinely audit severity characterization and clinical context against what the physician has documented in the chart. Using claims management software that validates ICD-10 entries at the point of submission helps catch these mismatches before a denial is issued.

Applicable to: Synonyms and inclusions for ICD-10 Code D66

The Applicable To note in the ICD-10-CM tabular list tells coders which clinical terms map to D66. Any of the following diagnoses, when documented by the treating physician, supports coding to D66 as verified by the AAPC ICD-10-CM code reference.

• Classical hemophilia (also called Hemophilia A; the most commonly used clinical term)
• Hemophilia A (congenital; the preferred modern terminology in hematology)
• Hemophilia NOS (not otherwise specified; use when the physician documents hemophilia without specifying type)
• Deficiency factor VIII (with functional defect) (specifically when the FVIII protein is present but non-functional rather than absent)

“Hemophilia NOS” is only appropriate when the physician’s documentation does not specify type A or type B. If the record clearly identifies Hemophilia B, D67 is the correct code instead.

Defaulting to D66 when type is unspecified, but the clinical context points strongly to factor IX involvement, is an error that auditors flag during post-payment review.

Excludes1 and Excludes2 notes for D66

The Excludes1 restriction on D66 is where most coding errors originate. Excludes1 means the two conditions cannot coexist in the same patient at the same time, so the excluded code can never be reported with D66 on the same claim.

Excludes1: D68.0 (factor VIII deficiency with vascular defect) is the code for von Willebrand disease when it also involves factor VIII. If the physician documents a factor VIII deficiency caused by a vascular or platelet adhesion problem, the hallmark of von Willebrand disease, the correct code is D68.0, not D66.

Coding both D66 and D68.0 on the same claim is a CMS-level edit violation that triggers automatic denial. Maintaining HIPAA-compliant coding workflows requires that coders verify the physician’s documented mechanism before assigning D66.

There are no Excludes2 notes on D66. Excludes2 would signal conditions that are related but separately reportable; that situation does not apply here.

Clinical overview: Hereditary factor VIII deficiency (Hemophilia A)

Hereditary factor VIII deficiency is a congenital bleeding disorder caused by deficient or dysfunctional clotting factor VIII. The condition is X-linked recessive, which means it primarily affects males while females are typically carriers. Clinical severity depends on residual factor VIII activity levels in plasma.

Documenting severity in the chart is critical, even though ICD-10 Code D66 does not have sub-codes for mild, moderate, or severe disease. Payers use the severity characterization in the physician’s note to validate medical necessity for high-cost factor replacement therapies.

A chart that simply states “hemophilia A” without a severity indicator can trigger a medical necessity denial, even when D66 is correctly coded. Structured patient records that prompt for severity documentation at the point of care reduce this risk.

Common signs include spontaneous bleeding into joints (hemarthrosis), soft-tissue bleeding, and prolonged bleeding after trauma or surgery. Diagnosis typically rests on factor VIII activity assays, APTT measurement, and genetic testing in family-history cases.

Recurrent hemarthrosis can cause lasting joint damage, and patients often need physical therapy providers experienced with hemophilic arthropathy for rehabilitation. Treatment agents commonly used alongside a D66 diagnosis include:

• Factor VIII concentrates: recombinant products including Advate, Helixate, and Kogenate
• Emicizumab (Hemlibra): a subcutaneous bispecific antibody that bridges factors IXa and X, used for prophylaxis including in patients with inhibitors
• Desmopressin (DDAVP): for mild Hemophilia A where residual factor VIII levels are sufficient to respond

Digital intake forms that capture family history of bleeding disorders and prior factor replacement therapy improve the quality of the initial clinical record, which in turn supports stronger coding specificity on every subsequent encounter.

ICD-10 Code D66 within the coagulation defects code hierarchy

Understanding where D66 sits in the ICD-10-CM tabular structure helps coders navigate adjacent categories correctly. The full hierarchy for D66 is shown below. This mirrors the structure in the official CDC/NCHS ICD-10-CM web tool, which is the primary reference for US code lookups.

The D65-D69 block covers a cluster of related hemorrhagic and coagulation disorders. Coders working in hematology or hemophilia treatment centers (HTCs) encounter most of these codes regularly.

D66 relates closely to adjacent codes such as D67 (factor IX deficiency) and D68 (other coagulation defects). Disseminated intravascular coagulation is coded separately under D65. The same specificity and exclusion-note principles that govern D66 apply across the entire D65-D69 range.

Related ICD-10 codes for coagulation defects

D66 is rarely the only code a hematology coder needs to know. The table below covers the codes most frequently encountered alongside or instead of D66, with guidance on when to use each.

Reduce coding errors before claims go out

Pabau's automated billing workflows flag ICD-10 mismatches and missing documentation before submission, so your team spends less time on rework and more time on patient care.

Book a demo

CPT codes commonly billed with ICD-10 Code D66

CPT codes are procedure-level; D66 is a diagnosis-level code. The table below lists CPT codes frequently paired with D66 on hematology claims. These pairings are reference information only. Actual billing must reflect the documented service and comply with payer-specific coverage policies. Hematology EMR workflows that surface common CPT-to-diagnosis pairings at scheduling reduce the manual lookup burden for coding staff.

ICD-9-CM to ICD-10-CM crosswalk for D66

Legacy systems and older payer contracts occasionally require ICD-9-CM equivalents for audit or historical claims reconciliation. The ICD-9-CM predecessor for D66 is 286.0, titled “Congenital factor VIII disorder.” This is an approximate match rather than an exact one-to-one equivalence, since the ICD-9 code covers the same clinical entity but with slightly broader scope.

For authoritative migration guidance, verify against the official CMS General Equivalence Mapping (GEM) crosswalk files rather than relying on commercial tools alone. When migrating codes through EHR integration, GEM files are the correct reference for mapping historical ICD-9 claims data to ICD-10.

Coding tips and common documentation errors for ICD-10 Code D66

Most D66 denials trace back to one of four documentation issues. Each one is preventable with the right workflow. Using practice management software with built-in coding prompts can surface these issues before a claim leaves the practice.

• Missing severity characterization. ICD-10 Code D66 does not distinguish mild, moderate, or severe Hemophilia A. But the physician’s note must still document severity because payers use that language to evaluate medical necessity for factor replacement dosing regimens. Code D66 plus document severity, even though the code itself does not reflect it.
• Coding D66 when von Willebrand disease is present. If the record indicates a vascular defect component, D68.0 is the correct code and D66 must not appear on the same claim. Query the physician if the documentation is ambiguous between Hemophilia A and von Willebrand disease.
• Using D66 for Hemophilia B. D67 is the correct code for factor IX deficiency. Defaulting to D66 for any “hemophilia” diagnosis without confirming the factor type is a common error among coders new to hematology.
• Combining codes incorrectly for complications. Hemarthrosis, intracranial bleeding, and other hemorrhagic complications have their own ICD-10 codes. D66 is the underlying disease code, and a complication code from the relevant body-system chapter may be added as a secondary diagnosis when the complication is the reason for the encounter. When that encounter is a hospital admission, sequence the complication as principal and D66 as secondary, alongside an admission code such as 99221.

Accurate documentation of D66 also matters beyond the claim itself. Structured automated billing workflows that flag incomplete fields at the point of chart completion help practices catch missing documentation in real time, rather than discovering it during a payer audit.

Conclusion

Hemophilia A billing hinges on two things: getting D66 right and keeping D68.0 off the same claim. Most denials in this space are documentation-driven, not code-selection errors. The code is straightforward. The challenge is ensuring physician notes carry the severity characterization and mechanism specificity that payers require to approve high-cost factor replacement therapy.

Pabau’s claims management software helps hematology and specialty practices catch ICD-10 mismatches, incomplete severity documentation, and Excludes1 violations before submission. If your billing workflow depends on manual code review, it is worth seeing how automated validation changes the picture. Book a demo to see it in action.

Continue your research

Need another recently added diagnostic reference? M35.3 covers polymyalgia rheumatica billing, another autoimmune-adjacent code hematology and rheumatology coders cross paths with.

Looking for an anesthesia billing example? 00942 shows how anesthesia CPT codes are structured and paired with a primary procedure.

Coding durable medical equipment claims? E0482 walks through a HCPCS billing scenario for a cough-stimulating device.

Need a lab-finding diagnosis code? R81 covers glycosuria, a common incidental finding coders encounter during routine workups.

Want a billing cheat sheet for another specialty? Pabau’s chiropractic billing cheat sheet template shows how one specialty organizes its CPT and ICD-10 references for faster claims.

Frequently Asked Questions